04/23/2024 7:21 PM | Arcus Biosciences (Filer)
| Form ARS | |
04/23/2024 3:08 PM | Arcus Biosciences (Filer)
| Form DEF 14A | |
04/23/2024 3:10 PM | Arcus Biosciences (Filer)
| Form DEFA14A | |
03/29/2024 3:20 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:19 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:30 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 6:55 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/28/2024 6:55 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:49 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4/A | |
02/21/2024 3:53 PM | Arcus Biosciences (Filer)
| Form S-3ASR | |
02/21/2024 3:16 PM | Arcus Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/09/2024 7:35 AM | Arcus Biosciences (Subject) FMR LLC (Filed by)
| Form SC 13G | |
02/07/2024 5:58 PM | Arcus Biosciences (Issuer) Mercier Johanna (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/31/2024 3:58 PM | Arcus Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D/A | |
01/31/2024 4:00 PM | Arcus Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 7:17 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 6:38 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:39 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 6:33 AM | Arcus Biosciences (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 10:52 AM | Arcus Biosciences (Subject)
| Form SC 13G/A | |
01/04/2024 4:22 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:23 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:44 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:47 PM | Arcus Biosciences (Subject) Goeltz II Robert C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 4:17 PM | Arcus Biosciences (Subject) Jaen Juan C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:20 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 3:06 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:09 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Goeltz II Robert C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:10 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:28 PM | Arcus Biosciences (Issuer) Azoy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 3:35 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
09/22/2023 3:16 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 3:46 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:47 PM | Arcus Biosciences (Issuer) Nuyten Dimitry SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 3:53 PM | Arcus Biosciences (Subject) Nuyten Dimitry SA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023 3:49 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023 7:08 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 7:13 AM | Arcus Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023 3:15 PM | Arcus Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:15 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 8:38 AM | Arcus Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D/A | |
06/30/2023 2:12 PM | Arcus Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 7:25 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 3:36 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:07 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 7:16 PM | Arcus Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:16 PM | Arcus Biosciences (Issuer) Jarrett Jennifer (Reporting) Jarrett Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:17 PM | Arcus Biosciences (Issuer) Tang Carolyn C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:01 PM | Arcus Biosciences (Issuer) FALBERG KATHRYN E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:03 PM | Arcus Biosciences (Issuer) KANEKO YASUNORI (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:05 PM | Arcus Biosciences (Issuer) Machado Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:06 PM | Arcus Biosciences (Issuer) Ribas Antoni (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:08 PM | Arcus Biosciences (Issuer) Lacey David L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:09 PM | Arcus Biosciences (Issuer) PERLMAN ANDREW J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:11 PM | Arcus Biosciences (Issuer) Lambert Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:12 PM | Arcus Biosciences (Issuer) ROSEN TERRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 7:14 PM | Arcus Biosciences (Issuer) Jaen Juan C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:19 PM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 3:12 PM | Arcus Biosciences (Subject) ROSEN TERRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 3:15 PM | Arcus Biosciences (Subject) Jaen Juan C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 3:18 PM | Arcus Biosciences (Subject) Jarrett Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 1:17 PM | Arcus Biosciences (Subject) Goeltz II Robert C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 7:25 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 7:34 AM | Arcus Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |